A small clinical trial with a pharmacokinetic sub-study, led by a world-renowned pharmacologist at the University of Houston, has demonstrated the promising effectiveness of the drug Riluzole for improving functionality in people with acute spinal cord injuries (SCI) if the drug is taken within 12 hours post-injury.
IQVIA and Propel to hold on deal close as FTC case proceeds
IQVIA’s proposed merger with Propel Media won’t close until at least Nov. 23, as a district court considers the FTC’s request to block the deal,
July 26, 2023